A 42-year-old was scheduled for a hysterectomy after decades of chronic pain. Then, a chance encounter led to a life-changing ...

The FDA has granted enVVeno Medical investigational device exemption approval to launch a pivotal U.S. study of its enVVe transcatheter venous valve for severe deep chronic venous insufficiency. The ...

April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...

First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal Trial Clinical site activation and patient enrollment ...

Dear Doctors: Can you please address chronic venous insufficiency? My doctor has advised me to use compression socks and elevate the legs. I find the socks hard to put on, and elevating my legs above ...

BD (NYSE:BDX) today announced the commercial launch of its CentroVena One insertion system, a central venous catheter (CVC) ...

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced the publication of a new study ...

Adopting next-generation technologies can help centers stay at the cutting edge of innovative care. However, the burden of ...

The TAVVE study will begin later this year with ten patients, whose 30-day safety results will be submitted to the FDA.

First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal TrialClinical site activation and patient enrollment expected to commence later this yearLarge unmet clinical need for approximately 3 ...

Transcatheter deep venous arterialization was tied to high rates of limb salvage and wound healing in patients with “no ...